JP2015524391A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524391A5
JP2015524391A5 JP2015520598A JP2015520598A JP2015524391A5 JP 2015524391 A5 JP2015524391 A5 JP 2015524391A5 JP 2015520598 A JP2015520598 A JP 2015520598A JP 2015520598 A JP2015520598 A JP 2015520598A JP 2015524391 A5 JP2015524391 A5 JP 2015524391A5
Authority
JP
Japan
Prior art keywords
composition
diffraction peak
crystal form
anhydride
pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015520598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015524391A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/048723 external-priority patent/WO2014005098A2/en
Publication of JP2015524391A publication Critical patent/JP2015524391A/ja
Publication of JP2015524391A5 publication Critical patent/JP2015524391A5/ja
Withdrawn legal-status Critical Current

Links

JP2015520598A 2012-06-29 2013-06-28 ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法 Withdrawn JP2015524391A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
US61/666,258 2012-06-29
PCT/US2013/048723 WO2014005098A2 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (2)

Publication Number Publication Date
JP2015524391A JP2015524391A (ja) 2015-08-24
JP2015524391A5 true JP2015524391A5 (cg-RX-API-DMAC7.html) 2016-08-18

Family

ID=49778754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520598A Withdrawn JP2015524391A (ja) 2012-06-29 2013-06-28 ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法

Country Status (17)

Country Link
US (2) US9040569B2 (cg-RX-API-DMAC7.html)
EP (1) EP2867216A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015524391A (cg-RX-API-DMAC7.html)
KR (1) KR20150037946A (cg-RX-API-DMAC7.html)
CN (1) CN104507918A (cg-RX-API-DMAC7.html)
AU (1) AU2013282286A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014032290A2 (cg-RX-API-DMAC7.html)
CA (1) CA2877941A1 (cg-RX-API-DMAC7.html)
EA (1) EA201590124A1 (cg-RX-API-DMAC7.html)
HK (2) HK1210163A1 (cg-RX-API-DMAC7.html)
IL (1) IL236476A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN10680A (cg-RX-API-DMAC7.html)
MX (1) MX2014015340A (cg-RX-API-DMAC7.html)
NZ (1) NZ628880A (cg-RX-API-DMAC7.html)
TW (1) TWI516283B (cg-RX-API-DMAC7.html)
WO (1) WO2014005098A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201409073B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590124A1 (ru) 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний
JP2017537958A (ja) * 2014-12-18 2017-12-21 メトリオファーム アーゲー 5−アミノ−2,3−ジヒドロフタラジン1,4−ジオンナトリウム塩の結晶形態、同一物を含む医薬製剤、及びこの形態の製造ための方法
KR20180105129A (ko) * 2015-11-30 2018-09-27 노부스 테라퓨틱스, 인크. 이과학적 예방 및 치료를 위한 조성물 및 방법
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
US20200085741A1 (en) * 2018-09-14 2020-03-19 Pharmosa Biopharm Inc. Pharmaceutical composition for controlled release of weak acid drugs and uses thereof
CN109827875A (zh) * 2019-04-10 2019-05-31 上海市食品药品检验所 一种用于测定吸入制剂溶出度的装置和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
CN1289248A (zh) * 1998-01-29 2001-03-28 维洛药品公司 治疗或预防肺病毒感染及有关疾病的化合物、组合物和方法
WO2002059132A1 (en) 2001-01-26 2002-08-01 Viropharma Incorporated Intermediate compounds useful for making antiviral compounds
US8202896B2 (en) 2002-08-09 2012-06-19 Microdose Therapeutx, Inc. Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1539691A2 (en) 2002-08-09 2005-06-15 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EA201590124A1 (ru) 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Similar Documents

Publication Publication Date Title
EA201591390A1 (ru) Пиразол[1,5-a]пиримидины для противовирусного лечения
NZ701647A (en) Compounds and methods for antiviral treatment
CA2818938A1 (en) Compounds for treating respiratory syncytial virus infections
AU2012358805A8 (en) Pyrazolo[1,5-a]pyrimidines as antiviral agents
AP3103A (en) Derivatives of purine or deazapurine useful for the treatment of (inter alia)viral infections
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
JP2015512931A5 (cg-RX-API-DMAC7.html)
WO2012027712A3 (en) Potent and selective inhibitors of hepatitis c virus
IL227990B (en) Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione for preparation of medicaments for treatment of immune-related and inflammatory diseases
ES2855159T8 (es) Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
HUE036220T2 (hu) Kinazolin származékok vírusfertõzések és további betegségek kezelésére
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
JP2009538861A5 (cg-RX-API-DMAC7.html)
WO2013055258A3 (ru) Применение глутарилгистамина для лечения заболеваний дыхательных путей
CL2013002031A1 (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-il oxi]-1-metil-1,4-diaza-espiro[5.5]undecan-5-ona; forma cristalina; compuestos intermediarios; procedimiento de preparacion; composicion y combinacion farmaceutica; y su uso para tratar enfermedades infecciosas o alergicas de las vias respiratorias.
TW201613931A (en) Form crystal of bisulfate of janus kinase (JAK) inhibitor and preparation method thereof
NZ740051A (en) Tetracycline compounds
IN2012DN06678A (cg-RX-API-DMAC7.html)
WO2010135170A3 (en) Nitrile derivatives and their pharmaceutical use and compositions
WO2012122450A3 (en) Peptide deformylase inhibitors
JP2014506577A5 (cg-RX-API-DMAC7.html)
JP2012533539A5 (cg-RX-API-DMAC7.html)
HRP20171227T1 (hr) Upotreba inhibitora vegfr-3 za liječenje hepatocelularnog karcinoma